AU2002310721A1 - Novel hormone composition - Google Patents
Novel hormone compositionInfo
- Publication number
- AU2002310721A1 AU2002310721A1 AU2002310721A AU2002310721A AU2002310721A1 AU 2002310721 A1 AU2002310721 A1 AU 2002310721A1 AU 2002310721 A AU2002310721 A AU 2002310721A AU 2002310721 A AU2002310721 A AU 2002310721A AU 2002310721 A1 AU2002310721 A1 AU 2002310721A1
- Authority
- AU
- Australia
- Prior art keywords
- hormone composition
- novel hormone
- novel
- composition
- hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0105557A FR2823976A1 (en) | 2001-04-25 | 2001-04-25 | NOVEL HORMONAL COMPOSITION AND ITS USE |
| FR01/05557 | 2001-04-25 | ||
| PCT/FR2002/001384 WO2002085375A1 (en) | 2001-04-25 | 2002-04-23 | Novel hormone composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002310721A1 true AU2002310721A1 (en) | 2002-11-05 |
Family
ID=8862668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002310721A Abandoned AU2002310721A1 (en) | 2001-04-25 | 2002-04-23 | Novel hormone composition |
Country Status (9)
| Country | Link |
|---|---|
| KR (1) | KR20030043797A (en) |
| CN (1) | CN1464787A (en) |
| AR (1) | AR033260A1 (en) |
| AU (1) | AU2002310721A1 (en) |
| BR (1) | BR0205104A (en) |
| FR (1) | FR2823976A1 (en) |
| MA (1) | MA26833A1 (en) |
| NO (1) | NO20026215L (en) |
| WO (1) | WO2002085375A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022053B2 (en) | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
| GT200500315A (en) * | 2004-11-02 | 2006-06-06 | SOLID ORAL DOSAGE FORMS CONTAINING A LOW ESTRADIOL DOSE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
| FR2754179B1 (en) * | 1996-10-08 | 1998-12-24 | Theramex | NOVEL HORMONONAL COMPOSITION AND ITS USE |
-
2001
- 2001-04-25 FR FR0105557A patent/FR2823976A1/en not_active Withdrawn
-
2002
- 2002-04-15 MA MA26603A patent/MA26833A1/en unknown
- 2002-04-23 KR KR1020027017624A patent/KR20030043797A/en not_active Withdrawn
- 2002-04-23 AU AU2002310721A patent/AU2002310721A1/en not_active Abandoned
- 2002-04-23 WO PCT/FR2002/001384 patent/WO2002085375A1/en not_active Ceased
- 2002-04-23 BR BR0205104-4A patent/BR0205104A/en not_active Application Discontinuation
- 2002-04-23 CN CN02802212A patent/CN1464787A/en active Pending
- 2002-04-24 AR ARP020101475A patent/AR033260A1/en not_active Application Discontinuation
- 2002-12-23 NO NO20026215A patent/NO20026215L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20026215L (en) | 2003-02-21 |
| WO2002085375A8 (en) | 2003-02-20 |
| AR033260A1 (en) | 2003-12-10 |
| FR2823976A1 (en) | 2002-10-31 |
| WO2002085375A1 (en) | 2002-10-31 |
| KR20030043797A (en) | 2003-06-02 |
| NO20026215D0 (en) | 2002-12-23 |
| CN1464787A (en) | 2003-12-31 |
| BR0205104A (en) | 2003-05-20 |
| MA26833A1 (en) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001234105A1 (en) | Cement composition | |
| EP1946882B8 (en) | Solder composition | |
| AU2002359200A1 (en) | New composition | |
| AU2001286233A1 (en) | Cement composition | |
| AU2002354251A1 (en) | Bactericidal composition | |
| AU2002345632A1 (en) | Tackifier composition | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AU2002258221A1 (en) | Medicinal composition | |
| AU2002241114A1 (en) | Composition | |
| AU2001241098A1 (en) | Composition | |
| AU2002254232A1 (en) | Photoresist composition | |
| AU2001275201A1 (en) | Acne-treating composition | |
| AU2001287852A1 (en) | Composition | |
| AU2001287732A1 (en) | Copolycarbonate-based composition | |
| AU2002354460A1 (en) | Medicinal composition | |
| AU2002310721A1 (en) | Novel hormone composition | |
| AU2001262163A1 (en) | Composition | |
| AU2002349452A1 (en) | Solvent composition | |
| AUPR529701A0 (en) | Pharmaceutical composition | |
| AU2002223691A1 (en) | Capillary composition | |
| AU2001236040A1 (en) | Skin-improving composition set | |
| AU2002238835A1 (en) | Fenofibrate-containing composition | |
| AU2002321593A1 (en) | Composition | |
| AU2002257631A1 (en) | Perticidal composition | |
| AU2002100853A4 (en) | Solid state composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |